1. 5-aminosalicylic acid versus salazopirin (SASP) in the oral treatment of active ulcerative colitis (UC) and in remission [abstract];Andreoli;Clinical Controversies in Inflammatory Bowel Disease,1987
2. Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity;Bresci;International Journal of Tissue Reactions,1990
3. Olsalazine versus sulfasalazine in the treatment of ulcerative colitis: Randomized controlled clinical trial;Cai;Chinese Journal of Digestion,2001
4. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study;D'Haens;Alimentary Pharmacology and Therapeutics,2006
5. Treatment of ulcerative colitis with olsalazine and sulfasalazine: efficacy and side effects;Ewe;Scandinavian Journal of Gastroenterology,1988